UnitedHealth Group Incorporated (UNH) is a publicly traded healthcare plans business based in the US. It opened the day at $493.13 after a previous close of $497. During the day the price has varied from a low of $463.89 to a high of $495. The latest price was $470.88 (25 minute delay). UnitedHealth Group Incorporated is listed on the NYSE. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Beginners
Best for
Mobile app
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $50 | £9.60 £1,930.09 total |
Capital at risk |
|
£0 | £250 | £17.80 £1,938.28 total |
Capital at risk |
|
£0 | £1 | £8.64 £1,929.13 total |
Capital at risk |
|
£0 | No minimum | £19.20 £1,939.69 total |
Capital at risk |
 |
£0 | £1 | £31.15 £1,951.64 total |
Capital at risk |
 |
£0 | £0.01 | £1.92 £1,922.40 total |
Capital at risk |
 |
£9.99 per month | No minimum | £36.80 £1,957.28 total |
Capital at risk |
 |
£36 per year | £20 | £33.51 £1,953.99 total |
Capital at risk |
 |
£0 | £50 | £9.60 £1,930.09 total |
Capital at risk |
Full comparison of share dealing platforms
Historical closes compared with the last close of $470.88
| 1 week (2023-01-27) | -3.12% |
|---|---|
| 1 month (2023-01-03) | -9.21% |
| 3 months (2022-11-03) | -13.38% |
| 6 months (2022-08-03) | -12.90% |
| 1 year (2022-02-03) | -3.66% |
|---|---|
| 2 years (2021-02-03) | 39.36% |
| 3 years (2020-02-03) | 71.84% |
| 5 years (2018-02-02) | 103.07% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
UnitedHealth Group Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, UnitedHealth Group Incorporated shares trade at around 23x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
UnitedHealth Group Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6567. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into UnitedHealth Group Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
UnitedHealth Group Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $31.8 billion (£26 billion).
The EBITDA is a measure of a UnitedHealth Group Incorporated's overall financial performance and is widely used to measure a its profitability.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like UnitedHealth Group Incorporated.
UnitedHealth Group Incorporated's total ESG risk: 20.65
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and UnitedHealth Group Incorporated's overall score of 20.65 (as at 01/01/2019) is pretty good – landing it in it in the 25th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like UnitedHealth Group Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
UnitedHealth Group Incorporated's environmental score: 0.53/100
UnitedHealth Group Incorporated's environmental score of 0.53 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that UnitedHealth Group Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
UnitedHealth Group Incorporated's social score: 14.36/100
UnitedHealth Group Incorporated's social score of 14.36 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that UnitedHealth Group Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
UnitedHealth Group Incorporated's governance score: 4.76/100
UnitedHealth Group Incorporated's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that UnitedHealth Group Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
UnitedHealth Group Incorporated's controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, UnitedHealth Group Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that UnitedHealth Group Incorporated hasn't always managed to keep its nose clean.
UnitedHealth Group Incorporated was last rated for ESG on: 2019-01-01.
| Total ESG score | 20.65 |
|---|---|
| Total ESG percentile | 24.52 |
| Environmental score | 0.53 |
| Environmental score percentile | 2 |
| Social score | 14.36 |
| Social score percentile | 2 |
| Governance score | 4.76 |
| Governance score percentile | 2 |
| Level of controversy | 3 |
| Open | $493.13 |
|---|---|
| High | $495 |
| Low | $463.89 |
| Close | $470.88 |
| Previous close | $497 |
| Change | $-26.12 |
| Change % | -5.2555% |
| Volume | 11,130,390 |
| 52-week range | $440.0988 - $556.3848 |
|---|---|
| 50-day moving average | $515.3558 |
| 200-day moving average | $515.918 |
| Wall St. target price | $598.3 |
| PE ratio | 23.4655 |
| Dividend yield | $6.4 (1.36%) |
| Earnings per share (TTM) | $21.18 |
Dividend yield: 1.36% of stock value
Forward annual dividend yield: 1.36% of stock value
Dividend payout ratio: 28.84% of net profits
UnitedHealth Group Incorporated has recently paid out dividends equivalent to 1.36% of its share value annually.
UnitedHealth Group Incorporated has paid out, on average, around 28.84% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.36% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 1.36% return on their shares, in the form of dividend payments. In UnitedHealth Group Incorporated's case, that would currently equate to about $6.4 per share.
While UnitedHealth Group Incorporated's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.
UnitedHealth Group Incorporated's most recent dividend payout was on 13 December 2022. The latest dividend was paid out to all shareholders who bought their shares by 2 December 2022 (the "ex-dividend date").
Over the last 12 months, UnitedHealth Group Incorporated's shares have ranged in value from as little as $440.0988 up to $556.3848. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while UnitedHealth Group Incorporated's is 0.7279. This would suggest that UnitedHealth Group Incorporated's shares are less volatile than average (for this exchange).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Blue Water Vaccines? We explain how and compare a range of providers that can give you access to many brands, including Blue Water Vaccines.
Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.
Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.
Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.
Ever wondered how to buy shares in NeuroSense Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including NeuroSense Therapeutics.
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.
Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.
